GlobalData on MSN

FDA approves GE HealthCare’s MIM Contour ProtégéAI+ 2.0 software

The tool aims to reduce planning time and help care teams create more tailored strategies.

GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities

GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug ...

GE HealthCare’s AI Oncology Push Targets Precision Care And Revenue Growth

GE HealthCare Technologies (NasdaqGS:GEHC) has received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 ...